• admin@ataxiatelangiectasia.es
Атаксия телеангиэктазия
  • Начинать
  • Что такое А-Т?
    • Anti-peptide Antibody Responses in Patients with Ataxia-telangiectasia
    • Ataxia-telangiectasia: Immunodeficiency and survival.
    • Comparison of major lymphocyte subpopulations and recent thymic emigrants in patients with ataxia telangiectasia and age-matched healthy groups.
    • Dietary intakes and nutritional issues in inborn errors of immunity: a systematic review
    • Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
    • Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia
    • Minimum effective betamethasone dosage on the neurological phenotype in patients with ataxia-telangiectasia: a multicenter observer-blind study.
    • Newborn screening for SCID identifies patients with ataxia telangiectasia.
    • Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network
    • Reconstitution of the Ataxia-Telangiectasia Cellular Phenotype With Lentiviral Vectors.
    • Treatment of Granulomas in Patients With Ataxia Telangiectasia.
    • Two Novel Mutations Associated With Ataxia-Telangiectasia Identified Using an Ion AmpliSeq Inherited Disease Panel.

    Language

      Russian (Russia)
    • Hindi (India)
    • Hebrew
    • Arabic (اللغة العربية)
    • Turkish (Turkey)
    • 日本語 (Japan)
    • Russian (Russia)
    • Français (France)
    • Deutsch (Deutschland)
    • Español (España)
    • Nederlands (nl-NL)
    • Português Brasileiro (pt-BR)
    • Polski (PL)
    • Italiano (Italia)
    • English (United Kingdom)

    Tweets by A_Tinfo

    Атаксия телеангиэктазия
      • Начинать
      • Что такое А-Т?
      • admin@ataxiatelangiectasia.es